PEDF is an extracellular multifunctional protein belonging to the serpin superfamily with demonstrable neurotrophic, gliastatic, neuronotrophic, antiangiogenic and antitumorigenic properties. We have previously provided biochemical evidence for high affinity PEDF-binding sites and proteins in plasma membranes of retina, retinoblastoma and CNS cells. This study was designed to reveal a receptor involved in the biological activities of PEDF. Using a yeast two-hybrid screening, we identified a novel gene from pigment epithelium of the human retina that codes for a PEDFbinding partner, which we term PEDF-R. The derived polypeptide has putative transmembrane, intracellular and extracellular regions, and a phosholipase domain. Recently, PEDF-R (TTS-2.2/iPLA 2 ζ, and mouse desnutrin/ATGL) has been described in adipose cells as a member of the new Ca-independent PLA 2 (iPLA 2 )/nutrin/patatin-like phospholipase domain containing 2 (PNPLA2) family that possesses triglyceride lipase and acylglycerol transacylase activities. Here, we describe the PEDF-R gene expression in the retina, its heterologous expression by bacterial and eukaryotic systems; and demonstrate that its protein product has specific and high binding affinity for PEDF, has a potent phospholipase A 2 activity that liberates fatty acids, and is associated to eukaryotic cell membranes. Most importantly, PEDF binding stimulates the enzymatic phospholipase A 2 activity of PEDF-R. In conclusion, we have identified a novel PEDF-R gene in the retina for a phospholipase-linked membrane protein with high affinity for PEDF, suggesting a molecular pathway by which ligand/receptor interaction on the cell-surface could generate a cellular signal.
PEDF is an extracellular multifunctional protein belonging to the serpin superfamily with demonstrable neurotrophic, gliastatic, neuronotrophic, antiangiogenic and antitumorigenic properties. We have previously provided biochemical evidence for high affinity PEDF-binding sites and proteins in plasma membranes of retina, retinoblastoma and CNS cells. This study was designed to reveal a receptor involved in the biological activities of PEDF. Using a yeast two-hybrid screening, we identified a novel gene from pigment epithelium of the human retina that codes for a PEDFbinding partner, which we term PEDF-R. The derived polypeptide has putative transmembrane, intracellular and extracellular regions, and a phosholipase domain. Recently, PEDF-R (TTS-2.2/iPLA 2 ζ, and mouse desnutrin/ATGL) has been described in adipose cells as a member of the new Ca-independent PLA 2 (iPLA 2 )/nutrin/patatin-like phospholipase domain containing 2 (PNPLA2) family that possesses triglyceride lipase and acylglycerol transacylase activities. Here, we describe the PEDF-R gene expression in the retina, its heterologous expression by bacterial and eukaryotic systems; and demonstrate that its protein product has specific and high binding affinity for PEDF, has a potent phospholipase A 2 activity that liberates fatty acids, and is associated to eukaryotic cell membranes. Most importantly, PEDF binding stimulates the enzymatic phospholipase A 2 activity of PEDF-R. In conclusion, we have identified a novel PEDF-R gene in the retina for a phospholipase-linked membrane protein with high affinity for PEDF, suggesting a molecular pathway by which ligand/receptor interaction on the cell-surface could generate a cellular signal.
Pigment epithelium-derived factor (PEDF) 1 , a non-inhibitory member of the serine protease inhibitor superfamily (SERPINS), is a multifunctional protein involved in neuronal survival and differentiation, in preventing angiogenesis and the growth of tumor cell metastases (1) (2) (3) (4) (5) (6) . It was discovered as a 50-kDa protein released by cultured pigment epithelial cells from fetal human retina (7) . In the retina, PEDF is highly expressed in the retinal pigment epithelium (RPE) (8, 9) , is enriched in the interphotoreceptor matrix (10) (11) (12) and has been implicated in photoreceptor morphogenesis (13) , and in vascular and neural retinal disorders (1) . It acts on photoreceptor survival (14) and in preventing the pathological invasion of neovessels (15) . Interestingly, its levels are decreased in choroidal neovascularization due to age-related macular degeneration (16) , and in diabetic retinopathy (17) . Its importance in the development, maintenance, and function of the retina is evident in animal models for inherited and light-induced retinal degeneration (14, 18) , retinal ischemia (19) , and ocular neovascularization (20, 21) .
However PEDF is not exclusive for the retina and is found in vitreous, aqueous humor, serum, cerebrospinal fluid and in most tissues, supporting its functions in extra-retinal systems (8, (22) (23) (24) . In this regard, PEDF induces neurite-outgrowth in developing motor neurons (25) , inhibits apoptosis of cerebellar granule cell neurons (26) , and protects hippocampal (27) , cerebellar granule cell and motor neurons against glutamate cytotoxicity (28, 29) . In contrast, it has antigliastatic activity on microglia from newborn rat brain (30) , and demonstrable pro-apoptotic effects on endothelial and tumor-derived cells, as well as in animal models for tumor growth (31) (32) (33) (34) (35) . PEDF null mice show the importance of PEDF in vasculature (31, 35) .
Although the structural determinants by which PEDF lost its ability to inhibit serine proteases are unknown, studies have demonstrated that 1) the PEDF protein has the three-dimensional structure of a serpin member with a homologous serpin reactive center loop (5, 36) ; 2) cleavage at this loop does not induce the typical serpin stress-to-relax conformational change of inhibitory serpins (37) and does not abolish its neurotrophic activities or binding affinities for glycosaminoglycans and collagens (26, (37) (38) (39) ; and 3) peptide regions toward its N-terminus and distal to the homologous serpin reactive center loop have demonstrable neurotrophic and antiangiogenic activities (25, 26, (40) (41) (42) (43) (44) .
Additional studies demonstrated that overexpression, and local or systemic administrations of PEDF promote survival of photoreceptors, inner retina and retinal ganglion cell neurons in experimental animal models for retina degeneration and ischemia; and inhibit neovascularization in numerous models for ocular angiogenesis (14, (18) (19) (20) (21) 45) . It has been shown that the PEDF action is cell-surface binding-mediated since its effects are blocked by antibodies that are cell-surface binding antagonists (12, 28, 40) . We and others have also provided biochemical evidence for high affinity PEDFbinding sites (K D = 2-8 nM) and proteins (80-90 kDa) in plasma membranes of retina, retinoblastoma, CNS, pericytes and endothelial cells, consistent with a cell-surface PEDF receptor protein (12, 40, 41, 43, 44, 46) . However, little is known about the identity of the receptor and molecular mechanism(s) by which PEDF functions to regulate neuronal and endothelial cell behavior.
In the present study, we investigated potential binding partners for PEDF using yeast two-hybrid screening and found a novel RPE gene, which we termed PEDF-R. We examined its gene expression and protein distribution in the retina. We expressed the PEDF-R protein, demonstrated its binding affinity for PEDF, characterized its phospholipase A 2 activity and mapped its transmembrane topology. These studies present evidence for the identification of a phospholipase on the surface of retina cells and imply a potential regulatory role for phospholipase-linked membrane protein in the biological actions of PEDF.
MATERIAL AND METHODS
Yeast two-hybrid screening -A two-hybrid system of Saccharomyces cerevisiae CG-1945 strain (Clontech, Palo Alto, CA, USA) was used as described previously by Baladron et al. (47) with the following modifications. The target was a human liver cDNA library (Human Liver MATCHMAKER cDNA Library, Clontech) with about 3 x 10 6 independent clones of 2 kb (mean cDNA size) having their 5'ends proximal to the Activation Domain (AD) of the GAL4 transcription factor in a pACT2 vector. The baits were PEDF cDNAs cloned in pAS2-1 plasmid (Clontech) with the binding domain BD at their 5'end. The PEDF inserts were PCR-amplified fragments encoding amino acids 35-418, 35-266, 35-229 , and 35-119 of the human PEDF (Accession number NM_002615; for primers see Fig. 1 ). The selection of the co-transformants was performed based on resistance to Leu -and Trp -. The selection of the interaction was performed based on His -medium. The intensity of the interaction was analyzed by 3-amino triazol (3-AT) assays in which yeast cells were cultured in minimal medium minus histidine and increasing concentrations of 3-amino triazol (0-100 mM), a competitive inhibitor of the yeast His3p protein used to eliminate background growth. All of the two-hybrid assays were repeated at least twice. The selected clones were used to remove the bait plasmids (PEDF) and isolate the AD containing plasmids followed by propagation in E. coli DH5-α cells (47) . The AD containing plasmids were candidate PEDF-interactants and their nucleotide sequences were determined using an ABI PRISM 310 sequencer (Applied Biosystems). The sequences were analyzed and compared to GenBank databases using a BLAST Search engine (http://www.ncbi.nlm.nih.gov/BLAST/) (48) . Several clones were false positives and were discarded as positive potential PEDF interactants due to lack of correct frame alignment or nonrelevant subcellular location (see Supplement Table S1 ). After verifying their open reading frames, the potential positive AD plasmids were isolated and cotransformed with shorter PEDF constructs, as described above. RNA isolation and cDNA synthesis -Total RNA was extracted using RNeasy™ (Qiagen) following manufacturer's instructions. The RNA was treated with TURBO DNase™ (Ambion) to remove genomic DNA contamination. An oligo(dT) probe was used to reverse-transcribe mRNA from cell samples in a final volume of 20 μl using SuperScript First-Strand Synthesis System (Invitrogen) following manufacturer's instructions. Polymerase Chain Reaction (PCR) -Specific primers for screening the expression of human PEDF-R within the 12c sequence were 12-forward, 5' AAC CCC TTG CTG GCG TTG C 3'; and 12-reverse, 5' CCC GTC TGC TCC TTC ATC C 3'. Alternatively, specific human PEDF-R primers were In2F-forward 5'GCA GTT TCC TGC TGA AGG TC 3' and In2R-reverse 5'GCT CGT CCT TGG AGT TGA AG 3'. Specific rat PEDF-R primers were rIn2F-forward 5' TGT GGC CTC ATT CCT CCT AC 3' and rIn2R-reverse 5' TGA GAA TGG GGA CAC TGT GA 3' (accession number XM_341960). Primers for 18S were 18S rRNA-F 5'ATG CTC TTA GCT GAG TGG CCC G 3' and 18S rRNA-R 5' ATT CCT AGC TGC GGT ATC CAG G 3'. Templates were PEDF-R cDNA and cDNAs prepared from tissues and cells in PCR SuperMix reactions following instructions by manufacturer (Invitrogen). The reversetranscription PCR reaction was performed in a final volume of 50 μl containing 2 μl cDNA and 10 μM primers specific for the PEDF-R gene with 18S or GADPH primers as a positive control using a thermocycler (Gen Amp PCR System 9700, PE Applied Biosystems) programmed in the following manner: initial denaturation at 94°C, 35 cycles of 15s at 94°C, 30s at 61°C, and 45s at 72°C, and 5 minutes at 72°C. PCR products were resolved by agarose gel electrophoresis and visualized with ethidium bromide. Immunohistochemistry of rat retina -Albino rat eyes (kind gift of Ignacio Rodriguez) were fixed in paraformaldehyde, embedded in paraffin and 7 µm thick sections were made using a microtome. The sections were deparaffined with xylene during 30 min and hydrated with alcohol in decreasing grade (100%, 90%, 70%, 50%, 30% and PBS) for 5 min each step. Then the non-specific binding sites were blocked with 5% BSA in PBS for 30 min. The sections were incubated 1 hour in anti-R C diluted 1:1,000 with PBS containing 1% BSA, 0.02% Tween-20, except the no primary control sections, which were incubated only in diluent without antibodies. After several washes with PBS, the samples were incubated in secondary Alexa 568-anti-chicken antibody diluted 1:300 with PBS containing 1% BSA, 0.02% Tween-20 during 1 hour. The slides were washed in PBS and stained with a DAPI solution (diluted 1:1,000 in 1% BSA in PBS) for 2 min. After wash with PBS, the samples were mounted with Gel/Mount Mounting Media (Biomeda) and observed under laser confocal microscope. Construction of expression vectors -Expression vectors for PEDF-R were constructed using ATCC IMAGE clone: 4875483 (ATCC number: 6903398, Accession number BC017280.1) as template for polymerase chain reactions (PCR) and recombining the amplified DNA products into expression plasmids using the Gateway™ Technology (Invitrogen). Briefly, PCR-amplified fragments encoding amino acids 1-504 and 250-383 of PEDF-R (PEDF-R, 212-1726 nucleotides and 12c, 957-1362 nucleotides) were used to create entry clones with pENRT/D-TOPO or pENTR/SD/D-TOPO by PCR-directional TOPO cloning. The entry clones were used to generate expression clones by recombination events. Primer sequences and expression constructs are listed in Table I . Final entry vectors had gene inserts flanked by lambda phage site-specific recombination attL sites and destination vectors had lambda phage site-specific recombination attR sites. The entry clones were used in a simple LR recombination reaction to transfer the PEDF-R or 12c cDNAs in pENTR/D to the destination vectors (pEXP1-DEST or pcDNA 6.2/N-Lumio DEST) to produce pEXP1-PEDF-R, pEXP1-12c or pLmN-PEDF-R plasmids, with N-terminal epitope-tagged genes of interest. Similarly, the PEDF-R and 12c cDNAs in pENTR/SD/D were transferred to the destination vectors (pEXP2-DEST or pcDNA 6.2/C-Lumio-DEST) to produce pEXP2-PEDF-R, pEXP2-12c or pLmC-PEDF-R with C-terminal epitope-tagged genes of interest. The cDNAs of interest in destination vectors were downstream from T7 transcription promoter and had ribosomal binding sites upstream from their start codons. The nucleotide sequences of the PEDF-R cDNA inserts in the entry and expression plasmids were confirmed (Loftsrand Labs). Prokaryotic expression of PEDF-R polypeptidesExpression of PEDF-R polypeptides was performed by cell-free in vitro protein synthesis using pEXP-based vectors and E. coli extracts from IVPS™ (Invitrogen) or RTS 100™ or RTS 500™ (Roche) systems following manufacturer's instructions. Expression of N-terminal epitopetagged PEDF-R polypeptides resulted in higher yields than of C-terminal tagged ones, and the former was chosen for the remaining of the assays. For protein solubility determination, aliquots of cell-free in vitro protein synthesis reaction mixtures were diluted 1:10 in phosphate buffered saline (PBS) with different additives (e.g. 10% glycerol, 0.1% NP-40, 0.5% CHAPS, 1-2 M NaCl, 2-8 M urea, SDS). After incubation at 25ºC for 30 minutes, the soluble (Sn) and particulate (pp) material was fractionated by centrifugation (14,000 x g, 25ºC, and 15 min). The proteins in Sn were precipitated with acetone to remove components of the reaction mixtures that interfere with the migration by the SDS-PAGE. The protein pellets were resuspended in SDS-PAGE sample buffer. Epitope-tagged PEDF-R polypeptides were detected by western blotting.
Epitope-tagged PEDF-R Protein PurificationPurification of 6xHis-tagged PEDF-R polypeptides from cell-free protein synthesis reactions was accomplished by cation-exchange column chromatography and/or His-tag affinity column chromatography using S-Sepharose Fast Flow (Pharmacia) resin and the ProBond Purification system with Ni-NTA resin (Invitrogen) following manufacturer's instructions. Automated purification of His-tagged polypeptides was accomplished with a POROS HS and/or a POROS MC column attached to a BioCad 700E computerized system. (See Supplementary Material for details). Purification from in vitro translation reactions yielded ~10 µg of 6xHis-tagged PEDF-R and ~0.5 mg 6xHis-tagged 12c per ml reaction with 50% and 90% purity, respectively. The final samples were used immediately or stored at 4ºC. The masses of tryptic peptides of purified N-end 6xHis-tagged PEDF-R polypeptide were in agreement with the coding sequence in pEXP1-PEDF-R, as confirmed by Nano LC-MS/Ms (by ProTech).
Proteins -Human recombinant PEDF protein and fluorescein-conjugated PEDF were prepared as described before (41 ), were generated and used to develop rabbit anti-R A antibodies (AnaSpec) and chicken anti-R C (Aves Lab). Protein analyses -Protein concentration determination was performed using Protein Assay (BioRad).
SDS-PAGE was performed using gradient 10-20% polyacrylamide gels in Tricine/SDS (Invitrogen). Western blots were as described before (12) . The apparent MW was estimated after SDS-PAGE and relative to prestained markers MW (MWs given by manufacturer varied from lot to lot). The relative mobilities (Rfs) for the markers were determined from several gels and plotted on semi-log graph paper. The apparent MW of PEDF-R proteins were determined from the curve in linear range and each was the average of more than 3 determinations. His-tag pull-down assays -Binding of PEDF to His-tagged PEDF-R polypeptides was assayed by His-tag pull-down of bound complexes with NiNTA resin. For PEDF-R:PEDF interactions, soluble aliquots of in vitro translation RTS 100 reactions containing 6xHis-tagged PEDF-R protein (~0.7 µg) were mixed with PEDF protein (4 µg) in binding buffer (50 mM phosphate-Na pH 7.5, 500 mM NaCl, 1% NP-40, 104 µl final volume) and incubated at 4ºC with gentle rotation for 2 hours. Then NiNTA resin beads (50 µl) preequilibrated in binding buffer containing only 0.1% NP-40 were added, and the suspension incubated for 1 hour at 4ºC with gentle rotation. For 12c:PEDF binding, Ni-NTA resin (50 μl) was mixed with purified N-end 6xHis-tagged 12c (~0.8 µg, fraction 33 of BioCad purification) in 200 μl binding buffer (50 mM phosphate-Na pH 8.0, 0.5 M NaCl). Mixtures were incubated and rotated for 30 min at 4°C and washed three times with binding buffer. PEDF (3 μg) in binding buffer was added to the resin suspensions and rotated 3 h at 4°C. The resin beads were sedimented by centrifugation, washed three times with binding buffer, and the proteins extracted with SDS-PAGE sample buffer (50 µl) and analyzed by western blotting against anti-PEDF antibodies. Complex-formation assay -PEDF:PEDF-R complex formation was assayed by size-exclusion ultrafiltration using Centricon-100 devices (Millipore), as described (38) . For PEDF-R:PEDF binding, soluble aliquots of epitope-tagged PEDF-R in RTS 100 reactions and PEDF were mixed as above for His-tag pull-down assays.
After incubation, mixtures were diluted in binding buffer containing 0.02% NP-40 (0.05% NP-40 final concentration), transferred to Centricon-100 devices and centrifuged at 1000 x g at 4ºC for 40 minutes or until most solution went through the membrane.
The concentrated material was washed with the same buffer two more times and analyzed by western blotting against anti-PEDF antibodies. Solid-phase assay -This assay was modified from that described for ELISA Femto™ (Pierce). PEDF was immobilized on 96-well plates by adding to each well 0.5 µg of PEDF diluted in 0.6 M Sodium Citrate, 0.1 M Sodium Carbonate, pH 9.0 (BupH Citrate-Carbonate Buffer Pack, Pierce) and incubation of 1 h at room temperature. After removal of excess solution, wells were washed with PBS. Blocking solution (1% BSA in Phosphate Buffered Saline, 0.05% Tween-20 (PBST)) was added to block non-specific sites for 1 h at room temperature. Soluble purified Histagged 12c was added to the wells and incubated at 4°C for 16 hours. After washing with blocking solution, Anti-HisG-HRP antibody (Invitrogen) diluted at 1:1000 or 1:10,000 was added and incubated for 1 hour at room temperature. The wells were washed three times with PBST, and ELISA Femto working solution (100 µl) was added to each well, incubated for 1 min. Then the luminescence was recorded by a luminometer (Wallac, Model 1450 Microbeta TRILUX). Negative controls included BSA immobilized on the plates instead of PEDF, no His-tagged 12c, or no antibody added to the reactions. Quantification and plotting was performed using Microsoft Excel Software. Surface Plasmon Resonance (SPR) assays -The interactions between PEDF and PEDF-R polypeptides were analyzed by SPR using a BIAcore 3000 instrument (BIAcore) with immobilized PEDF, ovalbumin or maspin ligands, as described previously (39) . Each ligand (4 ng) was immobilized on a CM5 sensor chip, by NHS/EDC activation, followed by covalent amine coupling of the protein to the surface. A reference surface without protein was prepared by the same procedure. All surfaces were then washed with 0.5 M NaCl and then re-equilibrated with binding buffer (0.01 M HEPES pH 7.4, 0.15 M NaCl HBS-N (BIAcore) plus 0.1% NP-40). Nine different dilutions of PEDF-R solutions with concentrations ranging between 0-50 nM were injected on the surfaces. Each injection was followed by a 50 mM NaOH regeneration step. The results were analyzed using BIAevaluation software. The data were then fitted to several binding models for a kinetic analysis. The best fittings were obtained with a simple 1:1 Langmuir model for the PEDF surface binding assay. Phospholipase (PLA) activity assay -The PLA activity was spectrophotometrically determined as described previously (49) with minor modifications. This assay uses [1,2-dilinoleoyl]-phosphatidylcholine as phospholipase substrate and lipoxygenase as coupling enzyme. The phospholipase activity releases linoleic acid from the substrate, and the lipoxygenase oxidizes the released linoleic acid to form a derivative hydroperoxide. The PLA activity was followed spectrophotometrically by measuring the increase in absorbance at 234 nm as a result of the formation of the linoleic acid hydroperoxide. Freshly prepared PEDF-R was incubated in 50 mM Tris-Cl, pH 7.5 buffer containing 3 mM deoxycholate in the presence of 0.26 mM phospholipase substrate (Sigma) and 12,226 units/ml of lipoxygenase (E.C.1.13.11.12, Sigma) in a final volume of 1 ml. Buffers for pH curve contained 3 mM Na-deoxycholate in 50 mM Naphosphate for pH 6.4 -7.4, 50 mM Tris-Cl for pH 7.0 -8.2, and 50 mM Na-borate for pH 8.0 -9.0. Spectrophotometric measurements were performed using a Beckman DU 640 spectrophotometer (Beckman Coulter, Inc.) A spectrophotometric scan of the products formed every minute for 10 min was obtained and the rate of absorbance change at 234 nm per minute was determined. The PLA activity, expressed as the rate of product formed, ΔAbs 234 /min was obtained using software from the spectrophotometer and rates were plotted using Microsoft Excel Software. Cell cultures -ARPE-19 cells were cultured in medium recommended by ATCC (1:1 mixture of Dulbecco's modified Eagle's medium and Ham's F12 medium containing 1.2 g/L sodium bicarbonate, 2.5 mM L-glutamine, 15 mM HEPES and 0.5 mM sodium pyruvate, 90%; fetal bovine serum, 10%) with 100 units/ml penicillin and 100 µg/ml streptomycin. R28 cells were a gift of Dr. Gail Seigel (University of Buffalo). RGC-5 cells were a gift of Dr. Neeraj Agarwal (U. North Texas Health Science Center). COS-7, RGC-5 and R28 cells were cultured in Dulbecco's Modified Eagle Medium, 10% Fetal Bovine Serum. 3T3-L1 cells were cultured in Dulbecco's modified Eagle's medium with 4 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10% bovine calf serum and 1% penicillinstreptomycin.
Eukaryotic expression of PEDF-R polypeptides -
Mammalian expression DNA vectors for PEDF-R were propagated in DH5α competent bacterial cells. DNA plasmids were purified from the bacterial cells using HiSpeed Plasmid Purification Midi Kit (Qiagen), following manufacturer's instructions, and concentrated by ethanol precipitation. Purified DNA plasmids (24 µg) for transfection were mixed with 60 µl of Lipofectamine 2000 (Invitrogen) diluted in Opti-MEM Reduced Serum Media (Invitrogen) and allowed to form complexes for 20 min at 25°C. DNA-Lipofectamine complexes were mixed with culture medium without antibiotics and added to mammalian cells (COS-7, ARPE-19, RGC-5, R28 or 3T3-L1) at ≥90% confluency in 10 cm plates in media without antibiotics. Cells were harvested or labeled with Lumio reagent 24 to 48 hours after transfection.
For stable transfection, cells containing plasmids were selected with culturing medium containing 3 µg/ml Blasticidin. Preliminary 'kill curves' with each cell type indicated successful selection of stably transfected cells with 1-10 µg/ml Blasticidin for at least 3 days (data not shown). Cell fractionation -Cells were harvested and subjected to differential centrifugation as we described previously (41) . Separation of final supernatant (cytosolic fraction) and particulate material (membrane fraction) for transfected cells was with 150,000 x g centrifugation and for ARPE-19 cells was with 80,000 x g. (See details in Supplementary Material). For Lumio in-gel visualization, fractionated cell samples were prepared for SDS-PAGE using the Lumio Green Detection Kit (Invitrogen) following the manufacturer's instructions. Lumio Green reagent was added to each sample, followed by addition of Lumio Enhancer. Lumio-labeled proteins in the gels were visualized using a Typhoon 9410 laser based scanner (Amersham) with a Green 532 nm laser and a 555 nm bandpass filter. Proteins in the gel were subjected to western blotting, staining with Ponceau Red, and immunoreactions with specific antibodies. In-cell detection of Lumio-tagged polypeptides was accomplished with Lumio Green Reagent 
RESULTS

Selection of PEDF-R by yeast two-hybrid
screening -A yeast two-hybrid screen performed with human PEDF cDNA fragments as baits and a human liver library as target revealed about 50 clones expressing proteins potentially interacting with GAL4BD-PEDF fusion proteins. Several of these clones had prospective positive coding sequences that matched known genes in GenBank databases. A clone termed 12c was selected among them for two reasons; first, it had a sequence that matched genes of potential interest, and second, colonies coexpressing it and pPEDF-1 tolerated 50 mM 3-AT, demonstrating strong interactions between PEDF and the protein encoded by the cDNA of clone 12c. New yeast cotransformations of clone 12c and four individual truncated PEDF constructs (Fig. 1) were plated with increasing 3-AT concentrations in selective media to confirm the PEDF:12c interactions. Only the colonies coexpressing clone 12c and an Nterminal half region of PEDF (35-229 amino acids positions, pPEDF-3) tolerated 3-AT above 10 mM, suggesting that the N-terminal portion of PEDF is implicated in the interactions with the polypeptide encoded by the 12c cDNA.
Alignment and comparison with GenBank databases showed that the nucleotide sequence of the 12c coding region aligned with 100% identity to a fragment of several homologous genes, one of them an unknown orphan mRNA from human liver (GenBank Acc. No. X56789) and another one from pigment epithelium of human retina (GenBank Acc. No. BC017280.1, official symbol PNPLA2 (see Fig. S1A) ), which at the moment of discovery were of unknown function. The high sequence identity found between these genes suggested that they are the same gene isolated from different tissues. Because the cDNA of the latter one was full-length and had been isolated from retina tissue, it was selected for the present study and we termed it PEDF-receptor (PEDF-R). Database searches and sequence analysis of PEDF-R -The availability of multiple genome, protein and EST databases facilitated the identification of several factors that may be crucial in elucidating the role of PEDF-R in humans. ENSEMBL (50) searches indicated that in humans PEDF-R maps to locus 11p15.5 on chromosome 11 and predicted it has 10 exons and 9 introns. Inspection of the PEDF-R cDNA sequence revealed mRNA transcripts of 2122 bases long with a coding capacity for a polypeptide of 504 amino acids (an expected molecular mass of 55315.11 daltons) and four N-glycosylation consensus sites ( Fig. 2A) . Hydrophobicity plots of the derived amino acid sequence anticipated up to four transmembrane domains (Fig. S1D ). TMpred and TOPpred programs predicted transmembrane positions with preferred orientations for the protein (Figs. 2B and 2C ). TMAP Prediction, TMHMM and Split Server predicted more than one position, while PSORT II was the only program that predicted a cytosolic protein.
In addition to the normal retinal pigment epithelium, the PEDF-R or derived fragments were found in nucleic acid sequences isolated from various organs and specific areas of interest and adipose tissue, such as optic nerve, choroid, foveal retina, macular retina and retinoblastomas as well as in cancerous tumors of different origins, indicating a ubiquitous character for PEDF-R. A BLASTn search of the GenBank™ database revealed that the PEDF-R sequence (Acc. Num. BC017280.1) was most closely related to comparable sequences in other species including Mus musculus (AK031609), Rattus norvegicus (XP_341961.1), Bos Taurus (XM_873300), Canis familiaris (XM_849071) and Gallus gallus (XM_428618). Further searches revealed that these sequences are putative orthologues of the human PEDF-R sequence and that a series of organisms including Caenorhabditis elegans (Acc No. NM_171168, and Anopheles gambiae (Acc No. XM_320608) also contain homologous similar sequences. BLASTp searches revealed that the relatedness is based upon an identified patatin-like domain, found through Pfam™ searches, to be from residues 10 to 179 on the human PEDF-R polypeptide.
Most importantly, this domain contains structural homologies to lipases GXSXG and DXG/A (Fig. 2D ) and was found conserved along a series of human sequences, particularly those within the newly described Patatin-like phospholipase domain containing 2 (PNPLA2)/Ca-independent PLA 2 (iPLA 2 )/nutrin family that includes PEDF-R, adiponutrin and GS2. Recently it was reported that the human TTS-2.2 (also known as iPLA 2 ζ,) and mouse desnutrin/ATGL described in adipose cells are homologue members of this new family of proteins (51) (52) (53) . Human TTS-2.2/iPLAζ (53) is identical to PEDF-R, while desnutrin (52) and ATGL (51) were discovered in mouse. Among human, rat and mouse species, PEDF-R is highly conserved (87% identity for both human/mouse and for human/rat, and 96% for mouse/rat), but the identity decreases significantly in the segment A ) in all species. The GS2 sequence, with only 253 amino acids, aligned with the N-terminal half of PEDF-R and lacked the 12c region. Expression of PEDF-R in ocular tissues and cellsGiven that the PEDF-R cDNA was originally isolated from the human RPE, its expression was examined in the retina. RT-PCR demonstrated amplification of specific PEDF-R fragments with cDNAs from human fetal and adult RPE tissue, as well as from established human RPE cell lines, ARPE-19 and hTERT (Fig. 3A) . The intensity of the amplified 12c fragment increased from fetal to adult human RPE, implying modulation of PEDF-R through development. Expression levels from RPE cDNAs were relatively lower than from human adipose cDNAs (Fig.3B) . Protein levels in ARPE-19 cells were also lower than in 3T3-L1 adipocytes (data not shown). Amplification of PEDF-R fragments was detected also in cDNAs from human normal retina and retinoblastoma Y-79, and rat retinal precursors R28 and RGC-5 cells, indicating PEDF-R expression in these cells. In agreement with previous studies (51, 52) , expression of PEDF-R transcripts was found in other human tissues and at higher levels in adipose tissue; and northern blots confirmed that human PEDF-R transcripts migrated as expected from the length of its sequence (~2.1 kb) (Fig. S2) .
Immunohistochemistry of rat retina with antibodies developed against synthetic peptide R C designed from a PEDF-R region with 100% amino acid sequence identity among human, mouse and rat species showed distribution of PEDF-R protein in the RPE and, at lower intensity, in the inner segments of photoreceptors and in the ganglion cell layer of the neural retina (Fig. 3C ). These observations were consistent with the expression pattern of PEDF-R transcripts described above. Binding of PEDF to bacterial recombinant PEDF-R polypeptides -To determine the binding affinity for the PEDF-R:PEDF interactions, we first expressed ectopically N-terminal His/Xpress tagged PEDF-R and 12c polypeptides in an in vitro cell-free E. coli expression system. Western analysis of reaction extracts driven by plasmids encoding 12c and PEDF-R revealed that the recombinant polypeptides had apparent MWs of 22,000 ± 3,000 and 69,000 ± 3,000, respectively, with Anti-Xpress antibodies (Fig. 4A) . Centrifugation of extracts demonstrated that the recombinant 12c and PEDF-R precipitated with storage time. However, treatments with detergents or chaotropic agents revealed that both polypeptides increased their solubility with 0.1% NP-40 or ≥4M urea (Fig. 4B) , consistent with the presence of putative hydrophobic TM regions in their sequences. Hence, 0.1% NP-40 was included in purification and storage buffers. Purification by Ni-NTA affinity column chromatography yielded ~0.5 mg of each epitope-tagged PEDF-R and 12c polypeptides per ml of expression reaction with 25-50% and 70-90% purity, respectively. Expression from the PEDF-R plasmid produced a second immunoreactive band of smaller MW (about 20,000) likely due to premature termination or degradation product and was not purified by affinity column chromatography (see Fig. 4A ). Proteins of about 28,000-MW (Fig. 4A, lane 7 ) present in the final purified sample were likely components of cell-free extracts with affinity for NiNTA (unpublished observations, L. Notari).
Several assays were then developed to test the interactions between the bacterially-derived recombinant PEDF-R polypeptides and PEDF. All the binding reactions contained 500 mM NaCl and 0.1% NP-40 to minimize protein aggregation and favor non-ionic interactions. Soluble epitopetagged PEDF-R and purified human recombinant PEDF were mixed and incubated to allow for binding. The mixtures were divided equally in two aliquots to separate the bound complexes from free PEDF by either His-tag pull-down or sizeexclusion ultrafiltration. We found that PEDF was pulled-down with Ni-NTA beads or retained by membranes (100,000-MW exclusion limit) only when His-tagged PEDF-R was included in the binding reactions (Fig. 5A ). This indicates that PEDF bound to PEDF-R forming a complex larger than 100-kDa, as expected for complexes between PEDF (50-kDa) and N-terminal His-tagged PEDF-R (69-kDa). Similarly, Ni-NTA beads pulleddown PEDF only when soluble purified Histagged 12c was included in the binding reactions (Fig. 5B) . The small size of 12c precluded sizeexclusion ultrafiltration assays, and a solid-phase binding assay was developed with PEDF immobilized on plastic wells and soluble Histagged 12c. Luminometry of horseradish peroxidase-conjugated anti-His showed significant luminescence in wells with His-tagged 12c additions compared to those without it, or in those wells in which bovine serum albumin replaced PEDF (Fig. 5C) . These results revealed specific binding of His-tagged 12c to immobilize PEDF.
To determine the biophysical binding parameters for the PEDF:PEDF-R interactions, Real Time Surface Plasmon Resonance assays were performed. Sensograms with PEDF protein immobilized on the surface of a CM5 sensor chip revealed binding response units for extracts of in vitro synthesis reactions driven by 12c and PEDF-R expression plasmids that were above reference cells (without PEDF) and were 10-fold and 4-fold of those for expression extracts with His-tagged lacZ-containing plasmids, respectively (not shown). These results indicated specific binding of each 12c and PEDF-R to PEDF. Kinetic analyses were performed with several batches of purified epitope-tagged PEDF-R. The kinetic parameters for the SPR interaction between PEDF and several different batches of epitope-tagged
M) were consistent with a 1:1 Langmuir binding implying a one-site binding (Fig. 5D ). PEDF-R rapidly and reversibly interacted with PEDF with typical saturation curve and the parameters revealed high binding affinity for the PEDF:PEDF-R interactions. The kinetic parameters between PEDF and two different batches of purified epitope-tagged 12c (k a = 3.57x10 3 ± 2.
-6 ± 2.11x10 -6 M) implied onesite binding, but revealed lower affinity (Fig. 5E) .
To compare the PEDF-R interactions among serpins, SPR was performed with immobilized maspin, ovalbumin and PEDF and epitope-tagged PEDF-R as analyte. PEDF-R had significantly lower binding to maspin than to PEDF and it did not have detectable binding to ovalbumin (Fig. 5F ) Phospholipase A 2 activity in PEDF-R -Sequence alignment revealed a patatin phospholipase-like region with a Ser/Asp dyad in PEDF-R resembling active sites in the catalytic domains of potato patatin B2 and human cytosolic PLA 2 (54) (see Fig. 2D ) and predicting phospholipase A 2 activity for PEDF-R. We investigated the potential PLA enzymatic activity of purified epitope-tagged PEDF-R with an assay that uses [1,2-dilinoleoyl]-phosphatidylcholine as PLA substrate and lipoxygenase as coupling enzyme (49) . In this assay, the PLA activity releases linoleic acid from the substrate that is oxidized by the coupling enzyme to form linoleoyl hydroperoxide, which is followed spectrophotometrically by measuring the increase in absorbance at 234 nm. The rate of absorbance (234 nm) change per minute increased linearly with purified epitope-tagged PEDF-R (Fig.  6A) . In one experiment we found that recombinant protein translated in the presence of NP-40 was more active than PEDF-R refolded after synthesis. However, because the purification yields for the refolded protein were significantly larger, this preparation was chosen for the remainder of the assays. The estimated specific activity of the refolded PEDF-R protein was 5.7 ΔA 234nm /min/nmole, while that of hog pancreas PLA 2 under identical buffer conditions was about four times lower (1.3 ΔA 234nm /min/nmole) (Fig.  6B) . Given that the iPLA 2 ζ (here identified as PEDF-R) contains a nucleotide sequence motif (G   14   CGFLG   19 ) (53), we examined whether ATP would have an effect on the PLA activity of PEDF-R by preincubating PEDF-R with 1 mM ATP for 15 min at 25ºC before assaying the PLA activity. No differences were observed between samples pretreated with or without ATP (Data not shown). A pH curve revealed optimum enzymatic activity at pH 7.5 for PEDF-R protein (Fig. 6C) . PEDF-R retained its activity when stored at 4ºC, but was lost immediately when stored at -20ºC (LN, personal observations).
These results demonstrate that bacterially-derived recombinant PEDF-R had a potent phospholipase activity, which was higher than that for hog pancreas PLA 2 when assayed under identical conditions. It has been demonstrated that bromoenol lactone, an inhibitor of iPLA 2 s, inhibits the triolein lipase activity of iPLA 2 ζ/PEDF-R (53). To determine whether the phospholipase activity of PEDF-R was inhibited by bromoenol lactone, the enzyme was preincubated with 25 µM bromoenol lactone or DMSO vehicle alone prior to assaying the PLA activity (Fig. 6D) . Bromoenol lactone blocked 40% of the PLA activity of PEDF-R, while DMSO alone did not affect the activity.
To investigate the effect of PEDF on the PLA activity of PEDF-R, aliquots of purified soluble PEDF-R (~0.15 pmoles) were preincubated with increasing amounts of PEDF to allow for binding. We found that the ΔA 234nm /min of the preincubated mixtures increased with the molar ratio (Fig. 6E ), but did not increase when BSA replaced PEDF, and PEDF alone did not contribute to this activity. In contrast, the activity of hog pancreas PLA 2 was not stimulated by PEDF in reaction conditions identical as for PEDF-R, i.e., with 0.01% NP-40, or when NP-40 was omitted (detergent included for PEDF-R solubility) (Fig. 6F) . Although inclusion of 0.01% NP-40 increased the hog PLA 2 activity, PEDF did not have a positive effect on it. Note that SPR kinetic parameters for the PEDF:PEDF-R interactions did not change significantly when binding was performed in the PLA reaction buffer containing 50 mM Tris-HCl, pH 7.5 and 3 mM deoxycholate, an ionic detergent that binds to proteins in solution through hydrophobic interactions of its cholesterol-like hydrocarbon structure (k a = 1.
. These results demonstrated that PEDF specifically stimulated the PLA enzymatic activity of the recombinant PEDF-R. Subcellular localization of PEDF-R -To investigate the subcellular localization of PEDF-R in eukaryotic cells, we ectopically expressed Lumio-/V5-tagged PEDF-R in epithelial COS-7, ARPE-19, retinal ganglion RCG-5, retinal R28, and fibroblastic 3T3-L1 cells. The Lumio-tag, a 6 amino acid peptide region containing four cysteines, has affinity for arsenical Lumio reagents, which upon binding unquench fluorescence to be detected by Laser scanning or microscopy. Laser scanning of gels after SDS-PAGE of protein extracts from cells transfected with N-terminal Lumio/V5-PEDF-R plasmids showed a band for protein migrating with an apparent MW of 81000 (Fig. 7A ). Western analyses with anti-V5 also showed one band with an identical migration pattern.
Cytosolic and membrane proteins of transfected cells were isolated following a previously optimized protocol for plasma membrane proteins (41) . Recombinant N-terminal Lumio/V5-tagged PEDF-R partitioned to both soluble cytosolic and particulated membrane fractions, and was not detected in the conditioned media, as shown by Laser scanning and western blotting with anti-V5 antibodies (Fig. 7A) . Quantitation of Lumio and V5-immunoreactivity in gels and western blots of equivalently loaded fractions from cells transfected with Lumio/V5-PEDF-R plasmids showed a cytosol:membrane PEDF-R ratio of 1:3 (compare lanes 3 and 4 in Fig.7A ), indicating preferential partitioning of PEDF-R to membranes. Fluorescence microscopy of cells transfected with Lumio/V5-PEDF-R plasmids showed homogeneous fluorescence in the cytosol, in a punctuated fashion excluding the nuclei and bordering the cells (Fig. 7B) . These results indicate that transiently overexpressed epitope-tagged PEDF-R partitioned in both cytosolic and membrane fractions, but preferentially as proteins from membranes, either inserted within the endoplasmic reticulum or at the cell-surface.
The subcellular localization was also investigated for the native PEDF-R in RPE cells. While ARPE-19 cell fractionation showed exclusive partition to the membrane fractions along with endoplasmic reticulum and plasma membrane markers and separate from lipid droplet marker TIP47 (Fig. 7C) , specific cell-surface protein biotinylation and isolation demonstrated that PEDF-R was in the cell-surface having extracellular biotinylation-sensitive regions (Fig.  7D ). Altogether these results provide biochemical evidence for PEDF-R as a plasma membrane protein.
Topology of PEDF-R -To investigate the potential transmembrane nature of PEDF-R, peptides R
A and R C (see scheme in Fig. 2C ) were synthesized and antibodies were developed. R A was designed from a region within the extracellular loop between TM3 and TM4, and next to the Nterminus of 12c. R C was designed from the intracellular loop between TM2 and TM3. Both antibodies Ab-R A and Ab-R C immunoreacted mainly with a single band in western blots of extracts from cells expressing PEDF-R, and their respective peptide antigens blocked these immunoreactivities (Fig. 8A) . The predicted extracellular and intracellular regions of PEDF-R were mapped using these antibodies and ARPE-19 cells.
Immunocytochemistry of nonpermeabilized ARPE-19 cells with Ab-R A showed immunolabeling of the cell surfaces, while the Ab-R C label was extremely low if any. In permeabilized ARPE-19 cells, both antibodies immunolabeled the cytoplasm and membranes with comparable intensities and patterns (Fig. 8B) . A radial structure arising from the nucleus area toward the plasma membrane was labeled with higher intensity. Controls without primary antibodies did not label cells. Similar observations were obtained with mouse 3T3-L1 cells with PEDF-R expression vectors (Fig. 3C ) and rat retinal RGC-5 cells. Cells overexpressing PEDF-R had a significantly higher level of staining than in those without PEDF-R expression vectors, revealing similar topology and subcellular location for the hetereologously and endogenously expressed PEDF-R (personal observations, R.H. and S.P.B.).
Together, these results clearly demonstrated that PEDF-R has extracellular and intracellular loops in agreement with the predicted topology. (Fig. 9) . The labeling pattern resembled the pattern obtained with the antibody to the extracellular peptide region R A in nonpermeabilized cells. The staining in ARPE-19 cells was visibly more intense around the nuclei where the density/thickness of the cell is increased, and similar to that reported for N-CAM, a surface marker for ARPE-19 (55) . Cells without Fl-PEDF did not show fluorescent signal. A similar Fl-PEDF labeling pattern was observed in 3T3-L1 cells (Fig. 9B) . The Fl-PEDF labeling pattern in 3T3-L1 cells stably expressing PEDF-R from expression vectors was identical to that without expression plasmids but at a much higher degree (Fig. 9C) , consistent with indiscriminately Fl-PEDF binding to the endogenous mouse PEDF-R and to heterologous expressed human PEDF-R. Furthermore, ligand competition showed that Fl-PEDF fluorescent signal in the presence of a 10-and 50-fold molar excess of unlabeled PEDF over Fl-PEDF decreased on the cell surfaces of L1[pPEDF-R] cells (Fig. 9C) . These results indicate that extracellular PEDF bound specifically to cells expressing PEDF-R in plasma membranes, as expected for ligand binding to cellsurface receptors.
PEDF binding to cell-surface PEDF-R protein
PEDF-R activity in ARPE-19 cells -PEDF-R in
ARPE-19 membrane fractions was assayed for PLA activity and the effect of PEDF was investigated. ARPE-19 cell membranes exhibited PLA activity (Fig. 10A) that was stimulated by PEDF ( Fig. 10B) with similar kinetics as demonstrated above for the recombinant PEDF-R. These results provide evidence for the PLA enzymatic activity of the membrane-associated PEDF-R, and most importantly, for its stimulation by PEDF binding.
DISCUSSION
In our investigations toward elucidating the mechanisms of action of PEDF in neuronal/retinal systems, we have previously provided biochemical evidence for high affinity PEDF-binding sites and proteins for PEDF in membranes of retina and CNS cells (40, 41, 43, 44) . Here, using yeast twohybrid screening, we identified a novel gene with characteristics for a PEDF receptor which we termed PEDF-R. This study is the first to identify PEDF-R, although its cDNA has been previously cloned and named independently by different groups. PEDF-R (TTS-2.2/iPLA 2 ζ, and mouse desnutrin/ATGL) has been recently described as a member of the new Ca-independent PLA 2 /nutrin/Patatin-like phospholipase domain containing 2 (PNPLA2) family that possesses triglyceride lipase and acylglycerol transacylase activities in adipose systems and likely to facilitate energy mobilization and storage in adipocytes (51) (52) (53) . Here, we describe the PEDF-R gene expression in retina cells, its heterologous expression by bacterial and eukaryotic systems, and we demonstrate that the PEDF-R protein binds to the PEDF ligand with high affinity, and that cell membranes contain the gene product. Most importantly, we demonstrate that PEDF-R exhibits phospholipase A 2 activity that liberates fatty acids, an activity that PEDF can stimulate.
We have performed an exhausting number of assays for the binding of PEDF to PEDF-R, in addition to yeast two-hybrid screening. It is demonstrated that these two proteins interact when they are in solution and when either one is immobilized. PEDF can bind to PEDF-R that is in vitro synthesized by bacterial extracts, in plasma membranes of mammalian cells overexpressing it, or in eukaryotically-derived cytosolic extracts (Fig.S4) . PEDF-R can retain binding affinity and PLA 2 activity after denaturing and refolding. The activities of bacterially-derived PEDF-R imply that eukaryotic post-translation modifications (such as N-glycosylation) are not structural determinants for PEDF-binding and PLA 2 activity of the PEDF-R polypeptide. Interestingly, the observed affinity of the interactions between the bacterially-derived PEDF-R and PEDF (K D = ~3 nM) is in agreement with the reported affinities of PEDF to receptors on the surface of cells that respond to PEDF (40, 41, 43, 44, 46) . Yeast twohybrid screening provided information of a potential PEDF-binding domain in PEDF-R, the 12c coding region (250-383 amino acids positions). However, there are reasons to believe that the 12c region contains incomplete structural determinants for PEDF binding: 1) lower drug tolerance of the yeast colonies coexpressing plasmids for PEDF and isolated clone 12c in the 3-AT assay demonstrate weaker interactions between fragment 12c and PEDF; 2) the amino acid sequence of the 12c region is not well conserved among species (human, mouse, rat, bovine, canine, Xenopus, Danio), in particular the segment A 267 RPH … EDH 295 (see Fig. S1B ); and 3) more conclusively, the affinity for the PEDF:12c interactions is three orders of magnitude lower than that of PEDF:PEDF-R.
Consistent with extracellular ligand binding, the N-terminal half of 12c maps to extracellular loop 4 that is available to interact with extracellular ligands. Interestingly, the 12c region contains homology to rat collagen I (PN, LN, and SPB, personal observations), suggesting a molecular basis for interacting with PEDF. The fact that the PEDF affinity for PEDF-R is higher than for rat tail collagen I (K D of 134 nM) (39) implies that the ligand/receptor binding might be mediated by stronger interactions in addition to those between PEDF and collagen-like regions in 12c of PEDF-R. It is assumed that additional regions from extracellular loops might contribute to the structural determinants in PEDF-R for extracellular ligand binding. It is also assumed that the decrease in sequence identity in the 12c region between PEDF-R and human adiponutrin/iPLA 2 ε (30% identity), and lack of this region in the truncated GS2/iPLA 2 η, suggest that PEDF-R might be the only likely family member with structural determinants for binding PEDF. Moreover, comparisons of PEDF-R binding affinities with other serpins, maspin and ovalbumin, indicate that PEDF might be a serpin with optimal structural determinants for interacting with PEDF-R.
Comparisons between the heterologous stably expressed PEDF-R and the previously reported PEDF-binding proteins isolated from retina plasma membranes (estimated apparent Mr ~80,000; (40,41)) revealed highly similar electrophoretic migration patterns among them. However, Jenkins et al. (53) subcloned the human iPLA2ζ (here identified as PEDF-R) from the same ATCC IMAGE clone as in this study, and reported a heterologous protein expressed in Sf9 cells with an apparent Mr of 57 kDa. Villena et al. (52) and Zimmerman et al. (51) also reported an apparent Mr of eukaryotically expressed mouse desnutrin (here PEDF-R) and ATGL (here PEDF-R) smaller than that in this study (53.6 kDa and 54 kDa, respectively). It is worth noting that in these three reports the lack of MW standards or their source precludes comparisons with our protein.
The difference in apparent MW between PEDF-R protein expressed in eukaryotic cells (81,000) and by in vitro reactions with bacterial extracts (69,000) is in agreement with four N-glycosylation group attachments on the polypeptide (increments of ~2500 per sugar attachment). Thus, we conclude that the apparent Mr of eukaryotically expressed PEDF-R is similar to the previously reported PEDF-binding proteins in plasma membranes (receptor) of human Y-79 cells, rat cerebellar granule cell neurons and bovine retina.
Our results provide detail information on the PEDF-R distribution of retina tissues and in cells. PEDF-R is a retina protein distributed to the RPE, the inner segments of photoreceptors and cells in the neural retina. The PEDF-R immunostaining in rat retina resembles the fluorescence of Fl-PEDF ligand binding sites in bovine retina reported previously (41) . In those studies the RPE exhibited autofluorescence and precluded visualizing Fl-PEDF binding sites in RPE cells. In the present study we observe that immunolabeled PEDF-R in the RPE is more intense toward the apical membrane than the basal suggesting a preferred apicolateral receptor distribution. Apicolateral preference is also suggested from the distribution of immunolabel around nuclei in nonpermeabilized ARPE-19 cells with antibodies against an extracellular region, implying protein localization on top of the cell, i.e., apical side. The distribution in inner segments of photoreceptors and ganglion cells of both PEDF-R and Fl-PEDF binding sites are in agreement with the PEDF action and ligand/receptor interactions in the retina (41) . Our observations are also in agreement with those of Jacob et al. (56) . They detected significant amounts of PLA 2 activity against 2-arachidonylphospholipids in two subretinal fractions adjacent to the rod outer segments, the RPE and another one presumably containing neuronal cells, Muller cells, and rod inner segments, but not in rod outer segments. Although, the identity of the protein in the RPE and retina with PLA 2 activity was not reported, they demonstrated that the activity is light-, Ca +2 -and Mg +2 -independent and optimal at pH 7.5-8.0, suggesting that the enzyme responsible for such activity might be PEDF-R. Furthermore, PEDF-R has been recently found modulated in the brain of animals depleted of serotonin or cathecholamine 2 implying a neuronal role for PEDF-R in the CNS.
In previous reports, observations regarding subcellular localization of desnutrin/ATGL proteins (here PEDF-R) were not comprehensive, as western and microscopy imagery illustrated their association to membranes, but claims were made only for cytosolic protein (51, 52) . Like adiponutrin (57), several programs predict up to four transmembrane (TM) domains interrupted by two extracellular loops and three intracellular regions for the PEDF-R protein. Consistent with this prediction, membrane fractions of PEDF-Roverexpressing cells contain most of the protein (estimated 75% of epitope-tagged PEDF-R of total COS-7, RGC-5, ARPE-19 cell extracts), which is not detected as a secreted protein. Note that we used the same fractionation protocol followed for the isolation of PEDF-binding proteins from retina plasma membranes (40, 41) , again, implying similarities between these proteins. Biochemical fractionation of RPE cells provides evidence for separation of PEDF-R from lipid droplet protein TIP47, in contrast to immunofluorescence of antibodies to ATGL in HeLa cells (Smirnova et al 2006) . Most conclusively, cell-surface labeling and mapping of predicted extracellular and intracellular loops with specific anti-peptides demonstrates that PEDF-R is a transmembrane protein on the surface of cells having an intracellular region between TM2 and TM3 and an extracellular region between TM3 and TM4. The latter region is likely to contain a PEDF-binding domain for PEDF-R.
The phospholipase A 2 domain is of great interest given that the enzyme is known to release bioactive fatty acids that function as second messengers or precursor of eicosanoids that mediate signal transduction (58) . Phospholipase PLA 2 can also release bioactive lysophospholipids involved in cell signaling and known to interact with their G protein-coupled receptors to influence the development, functions, and diseases of every mammalian organ system (59) . In previous reports on the members of the nutrin/Ca-iPLA family the authors demonstrated assiduously their triglyceride lipase activities that liberate fatty acids in paradigms for adipose systems. The present study demonstrates that the PEDF-R protein is also a functional phospholipase enzyme with an activity several fold that of hog pancreas PLA 2 (EC 3.1.1.4), and capable of being stimulated by PEDF. The substrate recognition site, formed by the homologous PLA 2 active serine (S47) and aspartic (D166) amino acids would face extracellularly in the predicted transmembrane topology of PEDF-R, suggesting release of products to the extracellular side.
The most abundant fatty acids in membrane phospholipids of the retina and CNS are arachidonic acid and DHA, known to be essential for proper neuronal function, and to exert survival effects on retinal and neuronal cells (60, 61) . Like PEDF, they have also been reported to have antitumorigenic and antiangiogenic properties, e.g., DHA is proapoptotic for tumor cells and growth (62, 63) . In this regard, Jenkins et al. (53) have claimed PLA 2 activity of iPLA 2 ζ (PEDF-R) with arachidonyl-sn-glycerol-3-phosphocholine supporting the release of arachidonic acid by PEDF-R. Although there is no empirical information of DHA release from phospholipids by PEDF-R, there is recent evidence for this fatty acid as a precursor for neuroprotectin D1, a retinal neuroprotectant, anti-inflammatory and antioxidative agent for the RPE, retina and CNS (64) (65) (66) Most interesting, PEDF at subnamolar concentrations is a potent activator of the synthesis and release of this DHA derivative from the apical side of human ARPE-19(67) 3 . These observations suggest that PEDF may exert survival actions in the neural retina via a lipid-signaling pathway mediated by PEDF-R. It is interesting to speculate that plasma membrane-associated PEDF-R may produce extracellular bioactive lipids, which can diffuse back into the cell as signaling molecules. PEDF, by binding to membrane-localized PEDF-R, may stimulate release of fatty acids and lysophospholipids, providing neuronal cells with higher survival or differentiation capability, and also rendering endothelial and tumor cells with irreversible cell damage.
Although detailed examination of this working hypothesis must be performed to claim such mechanisms of action for PEDF, our results suggest a molecular pathway by which receptor/ligand interaction on the cell surface could generate a cellular signal to promote its biological activities.
Additional studies are also necessary on PEDF internalization and on potential PEDF stimulation of the triglyceride lipase and acylglycerol transacylase activities of the cytosolic PEDF-R protein. PEDF may also stimulate the cellular release of bioactive lipids, e.g., free fatty acids and lysophosphatidic acid, via the cytosolic phospholipase and triglyceride activities of PEDF-R to act as secondary messengers or for lipid remodeling in the retina. There is evidence for lipid metabolism in the RPE and the existence of retinosomes (retinyl ester storage particles), particles reminiscent of lipid bodies identified in RPE as distinct structures compartmentalizing a metabolic intermediate involved in regeneration of the visual chromophore (68). The RPE undergoes phagocytosis of outer segments of photoreceptors as light induces transduction signals.
It is suggested that age-related loss of efficiency in phagocytosis and lipid accumulation in the RPE cells are due to a likely alteration in lipid metabolism. In early age-related macular degeneration, lipid-containing deposits (drusen) accumulate in Bruch's membrane underlying the retinal pigment epithelium (RPE). Bruch's membrane lies at the critical juncture between the outer retina and its blood supply, the choriocapillaris. Lipid deposition causes reduced hydraulic conductivity and macromolecular permeability in Bruch's membrane and is thought to impair retinal metabolism. There is histochemical evidence for an age-related increase in esterified and free fatty acids in human Bruch's membrane that accumulate in extracellular droplets (69) . Further investigations are necessary to reveal whether PEDF-R together with PEDF may interact with intracellular retinosomes and/or with extracellular drusen adjacent to RPE cells.
In conclusion, we have identified a novel PEDF-R receptor that is a lipase-linked membrane protein with high affinity for PEDF. Binding of PEDF to the extracellular loop between TM3 and TM4 of PEDF-R on the cell surface may mediate its neurotrophic effects and the promotion of neuronal survival and differentiation. Our data suggest that PEDF supports neural survival and differentiation by stimulation of neural-surface fatty acid/lipid metabolism, which in turn may regulate neural physiology by established mechanisms. The PEDF:PEDF-R interactions may also mediate its antiangiogenic and antitumorigenic activities by stimulation of lipid mediators with proapoptotic properties. These results provide a mechanistic insight with respect to the biological action and signaling pathways of PEDF. A. PCR-amplified fragments encoding human PEDF amino acids (as indicated on top of each line) were cloned into pAS2-1 vector using EcoR 1 and Sal I restriction sites. Fragments were obtained with primers hPEDF219U33 + hPEDF1373L36 for pPEDF-1, hPEDF219U33 + hPEDF914L35 for pPEDF-2, hPEDF219U33 + hPEDF803L39 for pPEDF-3 and hPEDF219U33 + hPEDF474L39 for pPEDF-4 (see panel B for primer sequences). Final constructs had GAL4 binding domain-PEDF fusion cDNAs. B. Primers used to prepare PCR-amplified fragments encoding human PEDF. The italicized portion of the primer sequence indicates the restriction site present in a PCR product prepared with that primer. The underlined portion of the sequence anneals to the PEDF-R gene. The TTA in bold of the primer sequence corresponds to the stop codon present in a PCR product prepared with that sequence. C. 3-AT assay for the interaction of PEDF with the truncated PEDF-R (clone 12c). CG1945 yeast colonies co-expressing the truncated human PEDF-R and one of the four different PEDF truncated proteins, encoded by plasmids pPEDF-1, -2, -3, or -4, were plated in selective media plates lacking leucine, tryptophan and histidine (-LTH) with increasing concentrations of 3-AT (0-100 mM). Labels correspond to: a, pPEDF-3; b, pPEDF-4; c, pPEDF-1; d, pPEDF-2. Labels for controls for protein-protein interactions were: e, pTD1-1 + pVA3-1 (positive control); f, pTD1-1 + pLAM (negative control); and g, pACT2 + pAS2-1 (empty vectors). 3) and the other half by complex formation after size-exclusion ultrafiltration through centricon 100 (C-100) (lanes 6-8). Westerns vs. anti-PEDF are shown. Lanes 4, 5 and 9 correspond to PEDF protein standards that were not subjected to binding assays. B. Pull-down assays of PEDF binding to purified His-tagged 12c. His-tagged 12c (~800 ng) was bound to Ni-NTA resin beads and then PEDF (3 µg) was added. Bound PEDF (Pull-down) was extracted with SDS-sample buffer and half was analyzed by western blotting vs. anti-PEDF. C. Solid-phase assay. His-tagged 12c was added to wells coated with PEDF or BSA. Bound His-tagged 12c was detected with Anti-HisG-HRP, and ELISA femto working solution followed by luminescence recordings. A. B. C. 
